Form 8-K - Current report:
SEC Accession No. 0000874716-22-000023
Filing Date
2022-05-13
Accepted
2022-05-13 16:00:51
Documents
14
Period of Report
2022-05-11
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K idxx-20220511.htm   iXBRL 8-K 50801
6 idxx-20220511_g1.jpg GRAPHIC 39045
  Complete submission text file 0000874716-22-000023.txt   308150

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT idxx-20220511.xsd EX-101.SCH 2250
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT idxx-20220511_def.xml EX-101.DEF 15127
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT idxx-20220511_lab.xml EX-101.LAB 29211
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT idxx-20220511_pre.xml EX-101.PRE 15699
8 EXTRACTED XBRL INSTANCE DOCUMENT idxx-20220511_htm.xml XML 11624
Mailing Address ONE IDEXX DRIVE WESTBROOK ME 04092-2041
Business Address ONE IDEXX DRIVE WESTBROOK ME 04092-2041 2075560300
IDEXX LABORATORIES INC /DE (Filer) CIK: 0000874716 (see all company filings)

EIN.: 010393723 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19271 | Film No.: 22922490
SIC: 2835 In Vitro & In Vivo Diagnostic Substances